bortezomib
takeda
['lymsm', 'borte', 'lymphoma', 'dlbcl']
congress #eha2022 | presented the final results of filveral 12 phase ii study of bortezomib + dhap in pts with r/r dlbcl. n=107, the primary endpoint was not met #lymsm #lymphoma 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm